English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/114276
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Título

Peroxisome proliferator-activated receptor γ agonist reduces the severity of post-ERCP pancreatitis in rats

AutorFolch-Puy, Emma ; Granell, Susana; Iovanna, Juan Lucio; Barthet, Marc; Closa, Daniel
Palabras clavePancreatitis
Nuclear factor κB
Inflammation
Endoscopic retrograde cholongio pancreatography
Peroxisome proliferator-activated receptor γ
Fecha de publicación28-oct-2006
EditorBaishideng Publishing Group
CitaciónWorld Journal of Gastroenterology 12(40): 6458-6463 (2006)
ResumenAim: To determine the effects of prophylactic peroxisome proliferator-activated receptor (PPARγ) agonist administration in an experimental model of post-endoscopic retrograde cholangiopancreatography (post-ERCP) acute pancreatitis. Methods: Post-ERCP pancreatitis was induced in male Wistar rats by infusion of contrast medium into the pancreatic duct. In additional group, rosiglitazone, a PPARγ agonist, was administered 1 h before infusion of contrast medium. Plasma and pancreas samples were obtained 6 h after the infusion. Results: Infusion of contrast medium into the pancreatic duct resulted in an inflammatory process characterized by increased lipase levels in plasma, and edema and myeloperoxidase activity (MPO) in pancreas. This result correlated with the activation of nuclear factor κB (NFκB) and the inducible NO synthase (iNOS) expression in pancreatic cells. Rosiglitazone reduced the increase in lipase and the level of edema and the increase in myeloperoxidase as well as the activation of NFκB and iNOS expression. Conclusion: A single oral dose of rosiglitazone, given 1 h before post-ERCP pancreatitis induction is effective in reducing the severity of the subsequent inflammatory process. The protective effect of rosiglitazone was associated with NFκB inhibition and the blockage of leukocyte infiltration in pancreas. © 2006 The WJG Press. All rights reserved.
URIhttp://hdl.handle.net/10261/114276
Identificadoresissn: 1007-9327
Aparece en las colecciones: (IIBB) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Folch-Puy-WJG-2006-v12-n40-p6458.pdf924,02 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.